Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 7Head & Neck 3Breast 3Thoracic 2Sarcoma 2Gynecologic 2Gastrointestinal 2Myeloid 1Lymphoid 1Dermatologic 1CNS 1

Conditions

Melanoma 143Carcinoma, Non-Small-Cell Lung 32Skin Neoplasms 27Colorectal Neoplasms 27Breast Neoplasms 26Lung Neoplasms 25Ovarian Neoplasms 20Neoplasms 20Carcinoma, Renal Cell 19Carcinoma, Basal Cell 19Squamous Cell Carcinoma of Head and Neck 18Prostatic Neoplasms 18Sarcoma 17Carcinoma, Merkel Cell 17Pancreatic Neoplasms 16Neoplasm Metastasis 14Head and Neck Neoplasms 13Thyroid Neoplasms 12Stomach Neoplasms 12Urinary Bladder Neoplasms 11Lymphoma, T-Cell, Cutaneous 11Carcinoma, Hepatocellular 10Uterine Cervical Neoplasms 9Esophageal Neoplasms 9Colonic Neoplasms 9Uveal Melanoma 8Mycosis Fungoides 8Multiple Myeloma 8Kidney Neoplasms 8Triple Negative Breast Neoplasms 7

Interventions

Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urologic Neoplasms × Dermatologic × 30 days × Clear all
NCT03093909 2026-05-20

Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

M.D. Anderson Cancer Center

Phase 1 Recruiting
44 enrolled
DermatologicGenitourinarySarcoma

Bone Neoplasms, Melanoma, Osteosarcoma, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡